Cargando…

Clinical Outcomes Associated With Escherichia coli Infections in Adults With Cystic Fibrosis: A Cohort Study

BACKGROUND: Analysis of “emerging” pathogens in cystic fibrosis (CF) lung disease has focused on unique pathogens that are rare in other human diseases or are drug resistant. Escherichia coli is recovered in the sputum of up to 25% of patients with CF, yet little is known about the epidemiology or c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edwards, B D, Somayaji, R, Greysson-Wong, J, Izydorczyk, C, Waddell, B, Storey, D G, Rabin, H R, Surette, M G, Parkins, M D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966422/ https://www.ncbi.nlm.nih.gov/pubmed/31976352 http://dx.doi.org/10.1093/ofid/ofz476

Ejemplares similares

1481. Clinical Outcomes of Escherichia coli Infections in Cystic Fibrosis (CF) Patients
por: Edwards, Brett, et al.
Publicado: (2018)

Epidemiology of E. coli in Cystic Fibrosis Airways Demonstrates the Capacity for Persistent Infection but Not Patient-Patient Transmission
por: Izydorczyk, Conrad, et al.
Publicado: (2020)

Stenotrophomonas maltophilia natural history and evolution in the airways of adults with cystic fibrosis
por: Izydorczyk, Conrad, et al.
Publicado: (2023)

The natural history and genetic diversity of Haemophilus influenzae infecting the airways of adults with cystic fibrosis
por: Izydorczyk, Conrad, et al.
Publicado: (2022)

Infection control knowledge, beliefs and behaviours amongst cystic fibrosis patients with epidemic Pseudomonas aeruginosa
por: Somayaji, R., et al.
Publicado: (2015)

65 Clinical outcomes of chronic “Prairie Epidemic Strain” Pseudomonas aeruginosa infection in adults with cystic fibrosis
por: Somayaji, R., et al.
Publicado: (2015)

Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis
por: Skolnik, Kate, et al.
Publicado: (2015)

Azithromycin and the microbiota of cystic fibrosis sputum
por: Acosta, Nicole, et al.
Publicado: (2021)

Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities
por: Acosta, Nicole, et al.
Publicado: (2020)

Epidemiology and natural history of Pseudomonas aeruginosa airway infections in non-cystic fibrosis bronchiectasis
por: Woo, Taylor E., et al.
Publicado: (2018)

Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response
por: Lam, John C, et al.
Publicado: (2015)

A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome
por: Woo, T. E., et al.
Publicado: (2019)

The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
por: Heirali, Alya A., et al.
Publicado: (2017)

Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis
por: Whelan, Fiona J., et al.
Publicado: (2017)

Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome
por: Sibley, Christopher D., et al.
Publicado: (2011)

Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections
por: Heirali, Alya, et al.
Publicado: (2016)

Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient
por: Workentine, Matthew L., et al.
Publicado: (2013)

Exploring the Cystic Fibrosis Lung Microbiome: Making the Most of a Sticky Situation
por: Thornton, Christina S, et al.
Publicado: (2022)

Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?
por: Skolnik, Kate, et al.
Publicado: (2017)

Phenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis
por: Duong, Jessica, et al.
Publicado: (2015)

Metastatic Bladder Cancer Presenting with Persistent Hematuria in Young Man with Cystic Fibrosis
por: Patel, Premal, et al.
Publicado: (2013)

Epidemiology and Outcomes of Community-Acquired Escherichia coli Pneumonia
por: John, Teny M, et al.
Publicado: (2021)

Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli
por: Burgess, Mary J., et al.
Publicado: (2015)

Clinical Impact of Ceftriaxone Resistance in Escherichia coli Bloodstream Infections: A Multicenter Prospective Cohort Study
por: Tamma, Pranita D, et al.
Publicado: (2022)

Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections
por: Sibley, Christopher D., et al.
Publicado: (2008)

Prevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study
por: Thornton, Christina S, et al.
Publicado: (2015)

Population-Based Incidence and Characteristics of Adult Escherichia coli Bloodstream Infection in Queensland, Australia, From 2000 to 2019
por: Ling, Weiping, et al.
Publicado: (2023)

The Niche for Escherichia coli Sequence Type 131 Among Veterans: Urinary Tract Abnormalities and Long-Term Care Facilities
por: Drekonja, Dimitri M., et al.
Publicado: (2016)

Epidemiology of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae That Are Piperacillin-Tazobactam-Nonsusceptible but Ceftriaxone-Susceptible
por: Baker, Thomas M, et al.
Publicado: (2018)

Genomic Epidemiology of Major Extraintestinal Pathogenic Escherichia coli Lineages Causing Urinary Tract Infections in Young Women Across Canada
por: Fibke, Chad D, et al.
Publicado: (2019)

Bacterial “Virulence” Traits and Host Demographics Predict Escherichia coli Colonization Behaviors Within Households
por: Fox, Teresa C, et al.
Publicado: (2020)

Multiple NDM-5-Expressing Escherichia Coli Isolates From an Immunocompromised Pediatric Host
por: Flerlage, Tim, et al.
Publicado: (2020)

Household Clustering of Escherichia coli Sequence Type 131 Clinical and Fecal Isolates According to Whole Genome Sequence Analysis
por: Johnson, James R., et al.
Publicado: (2016)

Long-Term Sentinel Surveillance for Enterotoxigenic Escherichia coli and Non-O157 Shiga Toxin-Producing E. coli in Minnesota
por: Medus, Carlota, et al.
Publicado: (2016)

Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study
por: Lazarovits, Gilad, et al.
Publicado: (2022)

The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-Lactams
por: Dufour, Nicolas, et al.
Publicado: (2017)

Incidence and Outcomes of Endophthalmitis Associated Hospitalizations in Children Aged ≤ 20 Years: A Population-Based Cohort Study
por: Edwards, Brett, et al.
Publicado: (2017)

Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic
por: Mathew, Hannah R., et al.
Publicado: (2021)

Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings
por: Boikos, Constantina, et al.
Publicado: (2016)

Multidrug Resistance of Escherichia coli From Outpatient Uncomplicated Urinary Tract Infections in a Large United States Integrated Healthcare Organization
por: Ku, Jennifer H, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0q149h8ed76onfh3qjl5gjhct0